tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
US Market

Avadel Pharmaceuticals (AVDL) Income Statement

Compare
697 Followers

Avadel Pharmaceuticals Income Statement

Last quarter (Q3 2024), Avadel Pharmaceuticals's total revenue was $50.02M, an increase of 613.22% from the same quarter last year. In Q3, Avadel Pharmaceuticals's net income was $-2.63M. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 27.96M$ 0.00$ 0.00$ 22.33M$ 59.22M
Gross Profit
$ 27.12M$ -1.49M$ -815.00K$ 16.59M$ 47.09M
Operating Expenses
$ 164.97M$ 95.22M$ 85.60M$ 53.25M$ 63.92M
Depreciation and Amortization
$ 1.77M$ 1.49M$ 815.00K$ 1.69M$ 2.49M
EBITDA
$ -149.13M$ -97.60M$ -84.78M$ -34.97M$ -23.61M
Operating Income
$ -137.85M$ -98.56M$ -85.55M$ -36.66M$ -16.83M
Other Income/Expenses
$ -22.93M$ -12.88M$ -7.60M$ -10.90M$ -14.47M
Pretax Income
$ -160.78M$ -111.44M$ -93.14M$ -5.08M$ -38.58M
Net Income
$ -160.28M$ -137.46M$ -77.33M$ 7.03M$ -33.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.00$ -2.29$ -1.32$ 0.13$ -0.89
Diluted EPS
$ -2.00$ -2.29$ -1.32$ 0.13$ -0.89
Weighted Average Shares Outstanding
80.17M 60.09M 58.53M 53.00M 37.40M
Weighted Average Shares Outstanding (Diluted)
80.17M 60.09M 58.53M 54.94M 37.40M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis